• COVID-19: Endemic Disease
  • Products
    • ASSURE-100 Home Tests
    • ASSURE-100 POC Tests
    • Buy ASSURE-100 Tests
  • News & Updates
  • Contact Us
Buy Tests
  • COVID-19: Endemic Disease
  • Products
    • ASSURE-100 Home Tests
    • ASSURE-100 POC Tests
    • Buy ASSURE-100 Tests
  • News & Updates
  • Contact Us
  • BUY TESTS
Latest COVID-19 Medications: Paxlovid, Remdesivir, and Best Practices for Testing

Latest COVID-19 Medications: Paxlovid, Remdesivir, and Best Practices for Testing

by Oceanit | Dec 30, 2024 | Education, General, Government

Latest COVID-19 Medications: Paxlovid, Remdesivir, and Best Practices for Testing The fight against COVID-19 has entered a new phase, with effective treatments and preventive measures helping to curb severe outcomes. Medications like Paxlovid and Remdesivir have...
Hawaii’s Journey Out of COVID-19: Resources and Recovery Efforts

Hawaii’s Journey Out of COVID-19: Resources and Recovery Efforts

by Oceanit | Dec 27, 2024 | Future, Government, Local News

Hawaii’s Journey Out of COVID-19: Resources and Recovery Efforts Hawaii Emerging from the COVID-19 Pandemic: State Resources and Key Insights Hawaii, with its unique geography and cultural richness, faced unprecedented challenges during the COVID-19 pandemic. As the...
NIH RECOVER Initiative: Advancing Research for Long COVID Solutions

NIH RECOVER Initiative: Advancing Research for Long COVID Solutions

by Oceanit | Dec 27, 2024 | General, Government, National News

NIH RECOVER Initiative: Advancing Research for Long COVID Solutions The NIH’s Ongoing Efforts in the Researching COVID to Enhance Recovery (RECOVER) Initiative: What It Is and How It Helps with Long COVID The COVID-19 pandemic has reshaped the landscape of global...
Pfizer Doesn’t Expect Major Vaccine Policy Changes From Trump in 2025

Pfizer Doesn’t Expect Major Vaccine Policy Changes From Trump in 2025

by Oceanit | Dec 27, 2024 | Future, Government

Pfizer Doesn’t Expect Major Vaccine Policy Changes From Trump in 2025 In a new article from Reuters, Pfizer Inc., a leading pharmaceutical company, declared that they do not expect significant vaccine policy changes under the incoming Trump administration in 2025....
COVID-19’s Impact on Hawaii’s Economy, Tourism, and Recovery

COVID-19’s Impact on Hawaii’s Economy, Tourism, and Recovery

by Oceanit | Dec 26, 2024 | General, Government, History

COVID-19’s Impact on Hawaii’s Economy, Tourism, and Recovery The COVID-19 pandemic upended lives and economies worldwide, with Hawaii experiencing particularly severe consequences. Renowned for its tourism-dependent economy and close-knit communities, Hawaii faced a...
Innovations and Inventions with Origins in Hawaii: From Surfboards to Rapid COVID-19 Testing

Innovations and Inventions with Origins in Hawaii: From Surfboards to Rapid COVID-19 Testing

by Oceanit | Dec 26, 2024 | Future, General, Government

Innovations and Inventions with Origins in Hawaii: From Surfboards to Rapid COVID-19 Testing Hawaii, often celebrated for its breathtaking beaches and vibrant culture, is more than just a tropical paradise. It has long been a hub of innovation and creativity,...
« Older Entries
Next Entries »

Recent Posts

  • New 2025 COVID Vaccine Rules: What They Mean for Americans
  • Summer 2025 COVID Trends: What to Know & How to Stay Safe
  • CDC Updates 2025 COVID-19 Testing, Isolation & Recovery
  • WHO Pandemic Treaty Aims to Prevent Future Health Crises
  • Should You Keep Rapid Tests for Spring & Summer 2025?

Recent Comments

No comments to show.
Copyright 2025 Oceanit Foundry LLC. The ASSURE-100 Rapid COVID-19 Test has not been FDA cleared or approved, but has been authorized by FDA under an EUA. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb- 3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
[dsm_icon_list list_alignment=”flex-end” _builder_version=”4.27.4″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” list_alignment_last_edited=”on|phone” list_alignment_phone=”center” sticky_enabled=”0″ list_alignment_tablet=”flex-end”][dsm_icon_list_child text=”Privacy Policy” use_icon=”off” url=”/privacy-policy/” _builder_version=”4.27.4″ _module_preset=”default” text_font=”Open Sans|700|||||||” text_text_color=”#e8e8e8″ text_font_size=”12px” text_text_color_last_edited=”off|desktop” global_colors_info=”{}” text_text_color__hover_enabled=”on|desktop” text_text_color__hover=”#1e73be”][/dsm_icon_list_child][/dsm_icon_list]